Kathleen Metters
Presidente presso SYNTARA LIMITED
Patrimonio netto: - $ in data 30/04/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Carl Firth | M | 51 |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | 14 anni |
Neil Graham | M | 65 |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | 4 anni |
Brian R. Wamhoff | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | 16 anni |
Robert Hoffman | M | 58 |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | 6 anni |
Gary Phillips | M | 62 | 21 anni | |
David Morris McGarvey | M | 67 | 22 anni | |
Andrew Howden | M | 64 |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | 8 anni |
Kiran Asarpota | M | 45 |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | 14 anni |
Tom Glocer | M | 63 | 17 anni | |
Dalton Smart | M | 58 | 15 anni | |
Simon Green | M | - | 2 anni | |
Chirfi Guindo | M | 58 | 13 anni | |
Richard O. White | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | 16 anni |
Robert Gould | M | 69 |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | 9 anni |
Peter Wendell | M | 73 | 21 anni | |
W. McIlwaine Thompson | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | - |
Stephen Doyle | M | 50 | 6 anni | |
Steven Graziano | M | - | 18 anni | |
Alexandre Kaoukhov | M | - | 2 anni | |
Michael Simmers | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | - |
Ryan Feaver | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | - |
Ajit Dash | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | - |
Kristen Morgan | F | - | 16 anni | |
John Brooks | M | 73 |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | 16 anni |
Denise Williams | F | - | 15 anni | |
Felicity Moffatt | M | - | - | |
Pamela Eisele | F | - | 15 anni | |
Reginald F. Woods | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | - |
Hashan de Silva | M | - | 1 anni | |
Ben Goodger | M | 61 | 8 anni | |
Sanat Chattopadhyay | M | - | 15 anni | |
H. Watkins | M | 71 |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | - |
David Manka | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | - |
Robert A. Figler | M | - |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | - |
James Matteucci | M | - | 21 anni | |
Jana Baskar | M | - | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Robert P. Luciano | M | - | 23 anni | |
Richard Kogan | M | 81 | 21 anni | |
Richard Clark | M | 77 | 6 anni | |
William L. Delaat | M | 72 | 25 anni | |
Paul Sekhri | M | 65 |
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | 4 anni |
Malcolm McComas | M | 68 | 20 anni | |
Fred Hassan | M | 78 | 6 anni | |
Harry R. Jacobson | M | 76 | 3 anni | |
Thomas Shenk | M | 77 | 11 anni | |
Jean-Marie Canan | M | 68 | 5 anni | |
Robert Iannone | M | 57 | 6 anni | |
Thomas Robert Cech | M | 76 | - | |
Ferda Cevikbas | M | - | - | |
Wendy Yarno | F | 69 | 9 anni | |
Rochelle Lazarus | F | 76 | 16 anni | |
James C. Powers | M | 71 |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | 14 anni |
Julie Gerberding | M | 69 | - | |
Simon Buckingham | M | 60 | 6 anni | |
Kenneth Bartizal | M | 72 | 20 anni | |
Craig Thompson | M | 71 | 10 anni | |
Ismail Kola | M | 67 | 4 anni | |
Charles Kidder | M | 79 | 12 anni | |
Steven Goldstone | M | 78 | 6 anni | |
Carole A. Sable | M | 62 | 16 anni | |
David Anstice | M | 75 | 5 anni | |
Brett Charlton | M | 67 | 24 anni | |
Natarajan Sethuraman | M | 62 | 10 anni | |
Carlos Eduardo Represas de Almeida | M | 78 | - | |
Laura Sepp-Lorenzino | M | 63 | 15 anni | |
Leslie Brun | M | 72 | 13 anni | |
Caroline Dorsa | F | 64 | 22 anni | |
Richard Henriques | M | 68 | 27 anni | |
Larry G. Edwards | M | 52 | 15 anni | |
Wendell Weeks | M | 64 | 16 anni | |
William N. Kelley | M | 84 | - | |
Jeffrey Leiden | M | 68 |
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | - |
William Harrison | M | 80 | - | |
Anne Tatlock | F | 84 | - | |
Francesco Maria Lavino | M | 51 | 2 anni | |
Juan Camilo Arjona Ferreira | M | 54 | 12 anni | |
Lisa Escudero | F | 62 | 18 anni | |
Barry Goldstein | M | - | 5 anni | |
Jeffrey Chodakewitz | M | 68 | 4 anni | |
Karen Ling | F | 60 | 6 anni | |
Terrie Curran | F | 55 | 4 anni | |
Patricia Maxson | M | 65 | - | |
David A. Esposito | M | 55 | 13 anni | |
Michael Atieh | M | 70 | 19 anni | |
Lawrence D. Senour | M | 59 | - | |
Mark Stejbach | M | 61 | 21 anni | |
Christopher Garland | M | - | - | |
Robert van Schoick | M | 73 | 28 anni | |
C. Nicholson | M | 68 | 2 anni | |
Michael R. Goldberg | M | - | 17 anni | |
Vijay Samant | M | 77 | 23 anni | |
Gerald McLaughlin | M | 56 | 11 anni | |
Robert G. Johnson | M | 72 | 7 anni | |
Christina Morrison | F | 57 | 4 anni | |
Mark E. McDonough | M | 59 | - | |
Albert I. Wertheimer | M | 81 | 3 anni | |
Peter G. Ernster | M | 82 | 26 anni | |
Bradley Sheares | M | 67 | 19 anni | |
Mirian Graddick-Weir | M | 69 | 12 anni | |
William G. Roberts | M | 66 | 6 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 81 | 81.00% |
Australia | 12 | 12.00% |
Singapore | 9 | 9.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Kathleen Metters
- Contatti personali